Skip to main content
Caplight Logo









BIOsens

BIOsens

Private
KyivHealthcare & Life Scienceshttps://sens.bio

Last Round

Grant

Jun 10, 2020

Total Funding Raised

$81,000

Company Overview

BIOsens operates in Healthcare & Life Sciences and is based in Kyiv. Its latest recorded funding round was a Grant round in June 2020.

BIOsens is a biotechnology company that develops portable diagnostic devices for rapid mycotoxin detection in food and agricultural products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Sensors, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BIOsens Comparables

Compare BIOsens with similar companies based on industry and business-model similarity.

BIOsens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ExciPlex
87%
Aflabox
85%
RapidBio Systems, Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BIOsens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 10, 2020
AcceleratorOct 3, 2019
GrantApr 1, 2019
AcceleratorNov 17, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BIOsens Investors

Notable investors and investment history

BIOsens investors
InvestorRounds
European Innovation CouncilGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors grew 169% MoM to 2.1K.

  • May 1, 2025

    Monthly visitors increased 58% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

BIOsens Filings

Explore SEC and related filing metadata, where available.

BIOsens filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BIOsens's valuation, stock price, and market status.

Is BIOsens a public or private company?

BIOsens is a private company.

What is the current stock price of BIOsens?

BIOsens is a private company, so its shares have no public market price. Caplight tracks BIOsens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BIOsens worth (valuation)?

Valuation information for BIOsens is not publicly available.

Can I buy BIOsens stock?

BIOsens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BIOsens's last funding round?

BIOsens's most recent funding round was Grant on June 10, 2020.

Who are the main investors in BIOsens?

Key investors in BIOsens include European Innovation Council.

Will BIOsens IPO soon?

No public IPO plans have been announced for BIOsens.

How can I track BIOsens secondary market activity?

Caplight tracks bids, offers, and trades in BIOsens's shares on secondary markets.

Firmographic Details

HeadquartersKyiv
Employee Range7
Year Founded2017
Last FundingJun 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?